Home > Insider Trading > Optimer Pharmaceuticals Inc

Optimer Pharmaceuticals Inc (OPTR)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

First
<< Previous
11 - 15

GlaxoSmithKline plc (ADR) (GSK) & Three Humongous Healthcare Stocks This Week

Last week, Obagi Medical Products, Inc. (NASDAQ:OMPI) made our list of humongous performers after Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced a $344 million bid for the company.

Keep Reading →

April 7th, 2013 - News

Johnson & Johnson (JNJ), Rigel Pharmaceuticals, Inc. (RIGL): This Week in Biotech

With the SPDR S&P Biotech Index up 22% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

April 7th, 2013 - News

Do Hedge Funds and Insiders Love Optimer Pharmaceuticals, Inc. (OPTR)? - ACADIA Pharmaceuticals Inc. (ACAD), Merrimack Pharmaceuticals Inc (MACK)

To most market participants, hedge funds are assumed to be slow, old financial vehicles of the past.

Keep Reading →

April 5th, 2013 - News

This Week in Biotech: Dynavax Technologies Corporation (DVAX), Zogenix, Inc. (ZGNX)

With the SPDR S&P Biotech Index up 23% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

March 5th, 2013 - News

3 Humongous Health-Care Stocks Last Week: Orexigen Therapeutics, Inc. (OREX), Optimer Pharmaceuticals, Inc. (OPTR)

While the overall market seemed to be deciding this week whether to keep the rally going or take a break, several stocks in the world of health care left no doubt.

Keep Reading →

March 4th, 2013 - News